Skip to main content

Table 5 Changes in anthropometric measures and blood pressure from baseline to 3 months by randomisation group

From: Breast cancer risk reduction - is it feasible to initiate a randomised controlled trial of a lifestyle intervention programme (ActWell) within a national breast screening programme?

 

Intervention

Control

 
  

Difference to baseline

  

Difference to baseline

Between group differences #

n

Mean (SD)

Mean (95% CI)

n

Mean (SD)

Mean (95% CI)

Mean (95% CI) p value

Body weight (kg)

Baseline

40

78.0 (16.5)

 

40

73.6 (18.7)

 

−2.04(−3.24 to −0.85)*

 

3 months

29

73.0 (14.3)

−2.04(−2.98 to −1.11)*

36

72.8 (19.3)

−0.04(−0.82 to 0.75)

p = 0.001

BMI (kg/m 2 )

Baseline

40

30.2 (6.5)

 

40

28.2 (7.4)

 

−0.77(−1.24 to −0.31)*

 

3 months

29

28.1 (5.6)

−0.79(−1.16 to −0.41)*

36

27.9 (7.5)

−0.03(−0.33 to 0.28)

p = 0.002

Waist Circumference

Baseline

40

98.7 (14.9)

 

40

93.6 (15.4)

 

−3.53(−5.50 to −1.57)*

(cm)

3 months

28

91.4 (11.6)

−4.41(−6.06 to −2.75)*

36

92.0 (15.6)

−0.79(−1.98 to 0.40)

p = 0.001

Mean systolic blood

Baseline

40

129.4 (13.1)

 

39

129.4 (17.7)

 

−2.81(−9.27 to 3.65)

pressure (mmHg)

3 months

28

130.9 (12.1)

0.59(−3.58 to 4.76)

34

132.6 (19.0)

4.05(−1.52 to 9.61)

p = 0.388

Mean diastolic blood

Baseline

40

78.6 (9.5)

 

39

78.8 (9.5)

 

−0.77(−4.22 to 2.69)

pressure (mmHg)

3 months

28

79.4 (6.1)

1.10(−1.46 to 3.66)

34

80.0 (9.9)

2.01(−1.06 to 5.07)

p = 0.659

  1. #Adjusted for baseline value *significant, p < 0.05.